151144-96-6 Usage
Uses
Used in Pharmaceutical Industry:
L-2-AMINO-4-BROMO-4-PENTENOIC ACID is used as a key intermediate in the synthesis of various pharmaceuticals. Its chemical structure and properties contribute to the development of potential drug candidates, facilitating the creation of new compounds with therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, L-2-AMINO-4-BROMO-4-PENTENOIC ACID serves as an essential intermediate for the production of crop protection products. Its role in the synthesis process aids in the development of effective and innovative solutions for agricultural challenges, enhancing crop yield and protection against pests and diseases.
Overall, L-2-AMINO-4-BROMO-4-PENTENOIC ACID holds significant potential in both the medical and agricultural fields, driving research and development of new compounds that address contemporary needs and challenges in these industries.
Check Digit Verification of cas no
The CAS Registry Mumber 151144-96-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,1,1,4 and 4 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 151144-96:
(8*1)+(7*5)+(6*1)+(5*1)+(4*4)+(3*4)+(2*9)+(1*6)=106
106 % 10 = 6
So 151144-96-6 is a valid CAS Registry Number.
151144-96-6Relevant articles and documents
Highly diastereoselective monoalkylation and Michael addition of N- (diphenylmethylene)glycinesultam under solid-liquid phase-transfer catalysis conditions using potassium carbonate as base
Lopez, Anna,Pleixats, Roser
, p. 1967 - 1977 (2007/10/03)
Treatment of a sultam-derived N-(diphenylmethylene)glycinate equivalent 1 with activated (allylic and propargylic) organic bromides and with Michael acceptors under solid-liquid phase-transfer catalysis conditions, using potassium carbonate as base, affords the monoalkylated compounds with high diastereoselectivity (>97% d.e.).
N-(Boc)-L-(2-bromoallyl)-glycine: A versatile intermediate for the synthesis of optically active unnatural amino acids
Leanna,Morton
, p. 4485 - 4488 (2007/10/02)
N(Boc)-L-(2-bromoallyl)-glycine (1) was synthesized from diethylacetamidomalonate and 2,3-dibromopropene in a one-pot procedure (75% overall yield). The enantiomers were efficiently separated via a tandem biocatalytic kinetic hydrolytic resolution. 1 was